Medicale Corp.
MCLE
$0.45
-$0.02-4.26%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -29.03% | 66.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -29.03% | 66.67% | |||
| Operating Income | 29.03% | -66.67% | |||
| Income Before Tax | 24.85% | -60.95% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 24.85% | -60.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 24.85% | -60.95% | |||
| EBIT | 29.03% | -66.67% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 27.59% | -61.11% | |||
| Normalized Basic EPS | 27.78% | -63.64% | |||
| EPS Diluted | 27.59% | -61.11% | |||
| Normalized Diluted EPS | 27.78% | -63.64% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
